Risk factors for intrahepatic cholangiocarcinoma: A possible role of hepatitis B virus

Journal of Viral Hepatitis

Volumn 17, Issue 10, 2010, Pages 742-748

  Tanaka, M ^a   Tanaka, H ^b   Tsukuma, H ^a   Ioka, A ^a   Oshima, A ^a   Nakahara, T ^c  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

aetiology; cholangiocarcinoma; cohort studies; hepatitis; inflammation; liver

Indexed keywords

ALANINE AMINOTRANSFERASE; CHOLESTEROL; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BILE DUCT CARCINOMA; BLOOD DONOR; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; COHORT ANALYSIS; FEMALE; FOLLOW UP; GROUPS BY AGE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR;

ADULT; ALANINE TRANSAMINASE; BLOOD DONORS; CHOLANGIOCARCINOMA; COHORT STUDIES; FEMALE; HEPACIVIRUS; HEPATITIS B, CHRONIC; HUMANS; JAPAN; LIVER NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 77956637818     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2009.01243.x     Document Type: Article

References (30)

1. Shaib Y, El Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis 2004 24: 115 125.
2. Vauthey JN, Blumgart LH. Recent advances in the management of cholangiocarcinomas. Semin Liver Dis 1994 14: 109 114.
3. Farley DR, Weaver AL, Nagorney DM. "Natural history" of unresected cholangiocarcinoma: patient outcome after noncurative intervention. Mayo Clin Proc 1995 70: 425 429.
4. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Cholangiocarcinoma Lancet 2005 366: 1303 1314.
5. Tanaka M, Tsukuma H. Epidemiology of cholangiocarcinoma. Nippon Rinsho (Japanese). 2009 67 (Suppl. 3 278 282.
6. Lee CH, Chang CJ, Lin YJ. Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma. Br J Cancer 2009 100: 1765 1770.
7. Lee TY, Lee SS, Jung ST et al. Hepatitis B Virus Infection and Intrahepatic Cholangiocarcinoma in Korea: A Case-Control Study. Am J Gastroenterol 2008 103: 1716 1720.
8. Zhou YM, Yin ZF, Yang JM et al. Risk factors for intrahepatic cholangiocarcinoma: a case-control study in China. World J Gastroenterol 2008 14: 632 635.
9. Shaib YH, El-Serag HB, Nooka AK et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study. Am J Gastroenterol 2007 102: 1016 1021.
10. El-Serag H, Engels E, Landgren O et al. Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: a population-based study of U.S. veterans. Hepatology 2009 49: 116 123.
11. Welzel TM, Graubard IB, El-Serag BH et al. Risk factors for intra-and extrahepatic cholangiocarcinoma in the United States: a population based case control study. Clin Gastroenterol Hepatol 2007 5: 1221 1228.
12. Shaib YH, El-Serag HB, Davila JA, Morgan R, McGlyn KA. Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology 2005 128: 620 626.
13. Yamamoto S, Kubo S, Hai S et al. Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma. Cancer Sci 2004 95: 592 595.
14. Donato F, Gelatti U, Tagger A et al. Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy. Cancer Causes Control 2001 12: 959 964.
15. Tanaka H, Tsukuma H, Yamano H et al. Prospective study on the risk of hepatocellular carcinoma among hepatitis C virus positive blood donors focusing on demographic factors, alanine aminotransferase, level at donation and interaction with hepatitis B virus. Int J Cancer 2004 112: 1075 1080.
16. Tanaka H, Tsukuma H, Hori Y et al. The risk of hepatitis C virus infection among blood donors in Osaka, Japan. J Epidemiol 1998 8: 292 296. (Pubitemid 128787384)
17. Kotani K, Maekawa M, Kanno T. Reestimation of aspirate aminotransferase/alanine aminotransferase ratio based on JSCC consensus method. Jpn J Gastro-enterology (Japanese) 1994 91: 154 161.
18. Watanabe J, Matsumoto C, Fujimura K et al. Predictive value of screening tests for persistent hepatitis C virus infection evidenced by viraemia. Japanese experience. Vox Sang 1993 65: 199 203.
19. Ajiki W, Tsukuma H, Oshima A et al. Osaka prefecture. In: Parkin DM, Whelam SL, Ferlay J, Teppo L, Thomas DB, eds. Cancer Incidence in Five Continents, Vol. 8. Lyon: IARC, 2002: 264 265.
20. International Agency for Cancer Research. Cancer Incidence in Five Continents, vol. 8. Lyon: IARC Scientific Publication No. 155, 2002.
21. Tsukuma H, Tanaka H, Ajiki W. Liver cancer and its prevention. Asian Pac J Cancer Prev, 2005 6: 244 250.
22. Kobayashi M, Ikeda K, Saitoh S et al. Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus-related cirrhosis. Cancer 2000 88: 2471 2477.
23. Okuda K. The Liver Cancer Study Group of Japan: primary liver cancers in Japan. Cancer 1980 45: 2663 2669.
24. Ikai I, Avii, Okazaki M et al. Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan. Hepatol Res 2007 37: 676 691.
25. Perumal V, Wang J, Thuluvath P, Choti M, Torbenson M. Hepatitis C and hepatitis B nucleic acids are present in intrahepatic cholangiocarcinomas from the United States. Hum Pathol 2006 37: 1211 1216.
26. Wang WL, Gu GY, Hu M. Expression and significance of HBV genes and their antigens in human primary intrahepatic cholangiocarcinoma. World J Gastroenterol 1998 4: 392 396.
27. Zou SQ, Qu ZL, Li ZF, Wang X. Hepatitis B virus X gene induces human telomerase reverse transcriptase mRNA expression in cultured normal human cholangiocytes. World J Gastroenterol 2004 10: 2259 2262.
28. Blechacz B, Gores JG. Cholangiocarcinoma. Advances in pathogenesis, diagnosis, and treatment Hepatology 2008 48: 308 321.
29. Meguro Parasitological Museum. The distribution and epidemiology of liver flukes in Japan. Prog Med Parasitol Jpn (Japanese) 1962 2: 359 361.
30. Shin HR, Lee CU, Park HJ et al. Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case control study in Pusan, Korea. Int J Epidemiol 1996 25: 933 940.